[Thyroid disorders]

M Schmidt1, H Schicha

  • 1Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Köln.

Versicherungsmedizin
|April 11, 2012
PubMed

In Germany, thyroid disorders have a long history. A sufficient iodine supply has been achieved in recent years in Germany. Thyroid nodules are frequent and mostly benign findings. Autonomous adenomas are not self-curable findings and require a definitive therapy, especially in the case of concomitant functional abnormalities (subclinical or overt hyperthyroidism). Graves' disease is the other most frequent cause of overt hyperthyroidism. In Germany, Graves' disease is treated with thyrostatic medication usually over 1-1 1/2 years, resulting in a definitive cure in about 50% of patients. In the case of therapy failure or high risk of relapse according to initial findings or complications under thyrostatic medication (leucopenia), definitive treatment mostly by way of radioactive iodine-131 is advised. Radioiodine therapy is usually well tolerated with minimal side effects and is not associated with risks such as laryngeal nerve palsy and hypoparathyroidism. Alternatively, surgical treatment is indicated in case of suspected malignancy or large thyroid volumes with relevant tracheal compression. Hashimoto's thyroiditis is the most frequent reason for hypothyroidism requiring levothyroxine substitution. In Germany, about 3500 women and 1500 men are diagnosed with papillary or follicular thyroid carcinoma each year which can be cured in the vast majority of patients. Less than 10% develop metastases after initial thyroidectomy and ablative radioiodine therapy. These patients can be treated with further therapy cycles of radioiodine. In the case of development of dedifferentiated iodine-negative, FDG-PET-positive metastatic disease treatment options are limited. In this situation, tyrosinkinase-inhibitors are a new treatment option which are being evaluated in current and prospective randomised controlled trials. Thyroid carcinoma (C73) is the most frequent reason for medical pensions because of thyroid disease. The rare anaplastic thyroid carcinoma is one of the most malignant tumours overall being usually fatal within a few months after diagnosis.

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...